cannabis and semaglutide The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs Clinician Supervised Select Plan:One Month Supply People with obesity and

cannabis and semaglutide The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs Clinician Supervised Select Plan:One Month Supply People with obesity and

People with obesity and alcohol use disorder had fewer heavy drinking days while on semaglutide (Wegovy), a Danish randomized trial showed. Semaglutide-treated adults also showed greater improvements across multiple secondary alcohol-related and

Clinical trials show that GLP-1 medications like semaglutide and tirzepatide can lead to a 15–20% weight reduction over 12–16 months, while diet and exercise typically result in 5–10% weight loss in the first year

Clinician Supervised

Select Plan:One Month Supply

Together with diet and activity changes, the aim is to reduce hunger and support a lower calorie intake